September 2006
Nasaleze natural cold prevention makes international debut
Hello everybody and welcome back to work. We hope you enjoyed the summer and the good weather that most of us were fortunate enough to have. As soon as we returned to work we were on a flight to Finland for the first market launch of our new product, Nasaleze Cold.
Our distributor, Polar Pharma, had organised a sales training session for their sales representatives on day one, followed by a press conference on day two.
The product was very well received by the press and attending medical professionals and we are hopeful of a number of good articles to help drive the sales.
Nasaleze Cold will be sold in both health food and pharmacy stores in Finland as a natural cold prevention product. Primary targets for the product will be those who regularly find themselves in situations where the likelihood of catching a cold is high. For example, school teachers, nurses, train commuters and frequent fliers etc.
|
 
|
Also, we hope to target professional sports players, who tend to suffer more colds than average resulting in them missing valuable training time and not being able to perform to their best. We are in discussions with the Finnish Ski Team with regards to them trialling the product this winter. Also, anyone who finds that they are susceptible to catching colds or who wish to avoid catching one would find this product of great use.
To create Nasaleze Cold we have added a special powdered garlic extract, European Wild Garlic, to the unique Nasaleze cellulose. European Wild Garlic manages to bring something new to the crowded filed of garlic products. Named the medicinal “Plant of the Year” of the Association for the Protection and Research on European Medicinal Plants, it is an old and once famous healing plant which is now the subject of renewed scientific interest. Wild garlic is so impressive because it has all the traditional healing and anti-viral properties of garlic yet it is odourless.
Safety studies and focus group studies have yielded positive results and clinical studies will be conducted this winter. We will keep you updated with the progress as we go along. A number of other markets will be launching the product in the next few weeks and then there are other distributors preparing to launch in January.
 |
 |
|
|
|
|
 |
|
|
